Skip to Main Content

Paper Details

RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDB.
Cancer Res
44
2019
-, 20 amino acid variable number tandem repeats, AKT3, ALKBH2, BCR, BRCA1, CASP1, CDK1, CDK1 and 20, CTNND1, Cancer, Cancer Cell Line, EGFR, ERBB2, FGFR2, FGFR3, HRAS, MUC1, NCI Almanac cell, NCI-60, NCI-60 cell lines, NCI-60 tissue of origin types, PTEN, RAD51, RNA, RNA processing and splicing genes, RNA-seq, TP53, acid, amino, androgen, androgen receptor AR-V4, benzaldehyde, cancer, cancer- and pharmacologically relevant genes, cell lines, genes, human, human cancer cell lines, imatinib, imexon, isoform transcript, palbociclib, pazopanib, pharmacologic gene sets, small cell lung cancer, transcript, vandetanib
Author NameAffiliation
William C ReinholdCenter for Cancer Research, National Cancer Institute, National Institutes of Health
William C ReinholdCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Sudhir VarmaCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Sudhir VarmaHiThru Analytics LLC
Sudhir VarmaCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Sudhir VarmaHiThru Analytics LLC
Margot SunshineCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Margot Sunshine
Margot SunshineCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Margot Sunshine
Fathi ElloumiCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Fathi Elloumi
Fathi ElloumiCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Fathi Elloumi
Paul S MeltzerCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Paul S MeltzerCenter for Cancer Research, National Cancer Institute, National Institutes of Health
James H DoroshowCenter for Cancer Research, National Cancer Institute, National Institutes of Health
James H DoroshowNational Cancer Institute, National Institutes of Health
James H DoroshowCenter for Cancer Research, National Cancer Institute, National Institutes of Health
James H DoroshowNational Cancer Institute, National Institutes of Health
Yves PommierCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Yves PommierCenter for Cancer Research, National Cancer Institute, National Institutes of Health
  • 1 - 22

Datasets

Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink